Molecular basis of cholestatic diseases of surgical interest

Area of Science:

• Hepatology and Molecular Medicine
• Pediatric Liver Diseases
• Genetic and Acquired Cholestasis

Background:

• Cholestasis is a frequent and severe liver disease manifestation in infants, often life-threatening.
• Current management frequently involves surgical intervention or liver transplantation.
• Recent research has significantly advanced the understanding of molecular mechanisms in pediatric cholestasis.

Purpose of the Study:

• To review recent advancements in the molecular basis of major pediatric cholestatic disorders.
• To consolidate knowledge on the underlying mechanisms of biliary atresia, Alagille syndrome, and familial intrahepatic cholestasis.
• To identify potential therapeutic targets for these conditions.

Main Methods:

• Comprehensive literature review of recent studies on pediatric cholestatic disorders.
• Analysis of experimental models and clinical data.
• Focus on molecular mechanisms and genetic underpinnings.

Main Results:

• Significant progress has been made in elucidating the molecular pathways of key pediatric cholestatic diseases.
• Specific genetic and molecular factors contributing to biliary atresia, Alagille syndrome, and familial intrahepatic cholestasis have been identified.
• Potential therapeutic targets, including interferon-gamma and Farnesoid X receptor, have been proposed.

Conclusions:

• Understanding the molecular basis of pediatric cholestasis is crucial for developing effective treatments.
• Further research into identified molecular targets may lead to novel therapeutic strategies.
• This review provides a foundation for future investigations into pediatric liver disease management.